MedTrace Logo

Post-discharge Pain After Breast-surgery Treated by Paravertebral Block

NCT03618459 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 244

Last updated 2018-08-07

No results posted yet for this study

Summary

Breast surgery is known being associated to a high risk of persistent post-operative pain, which has been related, among other factors, to a poorly treated acute pain. Paravertebral block has been successfully employed for anesthesia and analgesia after breast surgery, however its impact on persistent post-operative pain has rarely been investigated. Aim of this study is to assess prevalence, characteristics and consequences of post-discharge pain and its correlation to the incidence of persistent post-operative pain development in a continuous cohort of patients undergoing breast surgery with a paravertebral block.

Investigators designed a prospective, observational study on a continuous cohort of adult patients undergoing breast surgery with a standardized thoracic paravertebral block performed before general anesthesia induction. Patients were subsequently interviewed 6 months after hospital discharge in order to assess the incidence, features and duration of post-discharge pain.

Conditions

  • Mastectomy, Segmental
  • Regional Anesthesia

Interventions

OTHER

Phone questionnaire

Patients were contacted by phone 6 months after surgery and, after oral consent, a standardized questionnaire was administered in order to inquiry about the length and nature of post-operative pain, the incidence of post-discharge pain, its characteristics, its impact on daily life, its treatment and its rate of chronicity

Sponsors & Collaborators

  • Ente Ospedaliero Cantonale, Bellinzona

    collaborator OTHER

  • Samuele Ceruti

    lead OTHER

Principal Investigators

  • Luciano Anselmi, MD · Ente Ospedaliero Cantonale, Bellinzona

  • Andrea Saporito, MD · Ente Ospedaliero Cantonale, Bellinzona

  • José Aguirre, MD · Balgrist

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2017-04-30
Completion
2017-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03618459 on ClinicalTrials.gov